View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 18, 2020

GeneME develops on-premise FRANKD mouth swab test for Covid-19

Polish biotech company GeneMe has developed FRANKD, a fast, scalable mouth swab test for Covid-19.

Polish biotech company GeneMe has developed FRANKD, a fast, scalable mouth swab test for Covid-19.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

The test can be completed on-premises in an average of 13-25 minutes and does not require any laboratory involvement.

The GeneMe FRANKD Covid-19 test has shown to have 100% sensitivity and 100% specificity by the Gdańsk University of Technology.

FRANKD provides results in less time than the International Health Organization(WHO)-recommended gold-standard reverse transcription polymerase chain reaction (RT-PCR) reference test.

With approval, results are automatically issued to each individual’s secure, free​ digital Yoti ID app​, a digital ID and credential management platform.

The company said that the test will cost £10 for businesses in the region, making it cost-effective to carry out daily on a mass scale and for point-of-entry testing at care homes, airports, offices and several other locations.

GeneMe founder and CEO and FRANKD developer Dawid Nidzworski said: “We are extremely pleased with the quality of the FRANKD test and the contribution it will make towards the fight against the coronavirus pandemic and its damaging effects on public health and society.”

Currently, the company is holding discussions with governments and businesses across Europe to introduce millions of tests in the next few months.

Unlike the scarce reagents used in RT-PCR tests, FRANKD test uses a patented enzyme to quickly produce a reliable result.

FRANKD is said to be scalable with five million monthly tests expected from August.

Due to the use of a portable machine analyser to amplify the virus within the sample, high test accuracy is expected to become possible.

The company said that 90 people can be tested at a time, every 30 minutes with one device, significantly reducing the testing cost.

The company expects European CE regulatory certification by early June.

Due to a specific web application, all 90 tests within a batch will be uniquely assigned to the correct owner prior to entering the analyser machine.

Currently, Yoti app is available in English. The app in French, Spanish, Polish and German will be released shortly.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network